MDT Medtronic (MDT) Q2 FY26 earnings call
Medtronic reported a strong second quarter, with both revenue and EPS exceeding expectations, signaling an acceleration in financial results driven by robust procedure volumes and innovative technology launches. The company raised its full-year revenue and EPS guidance, fueled by significant momentum in its PFA franchise and the anticipated ramp-up of Symplicity and Altaviva. Management is strategically increasing OpEx investments to capitalize on market opportunities while maintaining a focus on portfolio management and tuck-in M&A.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
MDT operating KPIs by quarter
| KPI | Jan 2026 Q3 FY26 | Apr 2026 Q4 FY26 | Jul 2026 Q1 FY27 | Change vs prior quarter |
|---|---|---|---|---|
| Installed base Touch Surgery | 1,000+This quarter, Touch Surgery installations increased over 20% sequentially and have now surpassed 1,000 systems globally.Source: earnings call transcript | 1,400+And our Touch Surgery Digital Ecosystem, well, it continues to represent a clear advantage with over 1,400 installations, up 30% plus sequentially.Source: earnings call transcript | 1,500+Today, Touch Surgery is used in more than 1,500 operating rooms globally, supporting AI-powered insights, collaboration and workflows.Source: earnings call transcript | — |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.